The Effect of Green Tea on the Expression of NPC1L1, ABCG5, and ABCG8 in the Intestine of High Fat Diets-induced Rats

Erna Susanti, Endang Susilowati

Abstract


BACKGROUND: Signaling pathways contributing to cholesterol efflux and inhibitory inflammation in atherosclerosis that has not been explored is the liver X receptor (LXR). Catechin as LXR agonist influences the expression of Niemann-pick C1 like 1 (NPC1L1) protein transporter that triggers the inhibition of cholesterol absorption. This study aimed to examine the effect of Catechins on the expression of intestinal transporters: NPC1L1, ATP-binding cassete-proteins G5 (ABCG5) and G8 (ABCG8).

METHODS: Twenty-five experimental animals were divided into five treatment groups, with 5 rats in each group. The groups were normal diet rats (group 1), high fat diets-induced rats (group 2), high fat diets-induced rats treated with 30 mg/kg body weight (BW) of Catechins (group 3), high fat diets-induced rats treated with 60 mg/kg BW of Catechins (group 4), and high fat diets-induced rats treated with 120 mg/kg BW of Catechins (group 5). After one-month, all rats were sacrificed, blood and intestine were collected. Lipid profile were determined enzymatically, mRNA levels were determined by reversetranscriptase polymerase chain reaction (RT-PCR), while the expression of protein transporter were determined by immunohistochemistry.

RESULTS: Catechins treatment decreased the expression of NPC1L1, but increased the expression of ABCG5 and ABG8.

CONCLUSION: Catechins can be developed as a candidate for NPC1L1 inhibitor to mediate the inhibiting absorption of intestinal cholesterol, therefore increasing the inhibitory effect of atherogenesis.

KEYWORDS: ABCG5, ABCG8, aterogenesis, Catechins, green tea, NPC1L1


Full Text:

PDF

References


Yang Z, Ming MF. Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin Med Res. 2006; 4: 53-65, CrossRef.

Velde AV. Reverse choleterol transport: from classical view to new insight. World J Gastroenterol. 2010; 16: 5908-15, CrossRef.

Meiliana A, Wijaya A. Inflammation and atherosclerosis. Indones Biomed J. 2012; 4: 73-83, CrossRef.

Calkin A, Tontonoz P. LXR signaling pathway and atherosclerosis. Arterioscler Thromb Vasc Biol. 2010; 30: 1513-8, CrossRef.

Wang X, Collins HL, Ranalletta M, Fuki IV, Billheimer JT, Tall AR, et al. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J Clin Invest. 2007; 117; 2216-24, CrossRef.

Murwani S, Ali M, Muliartha K. Diet aterogenik pada tikus putih (Rattus novergicus strain wistar) sebagai model hewan aterosklerosis. Jurnal Kedokteran Brawijaya. 2006; 22: 6-9, CrossRef.

Artiss JD, Zak B. Measurement of cholesterol concentration. In: Handbook of Lipoprotein Testing. Washington: AACC Press, 1997. p.99-114, NLMID.

Kaemmerer D, Peter L, Lupp A, Schulz S, Sanger J, Baum R, et al. Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors. Int J Clin Exp Pathol. 2012; 5: 187-94, PMID.

Cimmino G, Ibanez B, Vilahur G, Speidl WS, Fuster V, Badimon L, et al. Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-I (Milano). J Cell Mol Med. 2009; 13: 3226-35, CrossRef.

Shrestha S, Ehlers SJ, Lee J, Fernandez M, Koo S. Dietary green tea extract lowers plasma and hepatic triglycerides and decreases the expression of sterol regulatory element-binding protein-1c mRNA and its responsive genes in fructose-fed, ovariectomized rats. J Nutr. 2009; 139: 640-5, CrossRef.

Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 2000; 290: 1771-5, CrossRef.

Wang J, Mitsche MA, Lütjohann D, Cohen JC, Xie XS, Hobbs HH. Relative roles of ABCG5/ABCG8 in liver and intestine. J Lipid Res. 2015; 56: 319-30, CrossRef.

Mohammadi A, Mirzaei F, Moradi MN, Jamshidi M, Yari R, Ghiasvand T, et al. Effect of flaxseed on serum lipid profile and expression of NPC1L1, ABCG5 and ABCG8 genes in the intestine of diabetic rat. Avicenna J Med Biochem. 2013; 1: 1-6, article.

Jia L, Better JL, Yu L. Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport. Annu Rev Physiol. 2011; 73: 239-59, CrossRef.

Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, et al. The target of ezetimibe is Niemann-pick C1-like 1 (NPC1L1). Proc Natl Acad Sci. 2005; 102: 8132-7, CrossRef.

Nakano T, Inoue I, Takenaka Y, Ono H, Katayama S, Awata T, et al. Ezetimibe promotes brush border membrane-to-lumen cholesterol efflux in the small intestine. PLoS One. 2016; 11: 1-27, CrossRef.

Braun A, Yesilaltay A, Acton S, Broschat KO, Krul ES, Napawan N, et al. Inhibition of intestinal absorption of cholesterol by ezetimibe or bile acids by SC-435 alters lipoprotein metabolism and extends the lifespan of SR-BI/apoE double knockout mice. Atherosclerosis. 2008; 198: 77-84, CrossRef.




DOI: https://doi.org/10.18585/inabj.v13i2.1420

Indexed by:

                 

                  

               

     

 

The Prodia Education and Research Institute